Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use-Reference-Cited by-同舟云学术

Risks of angiotensin-converting enzyme inhibition during pregnancy: Experimental and clinical evidence, potential mechanisms, and recommendations for use

Published:1994-05 Issue:5 Volume:96 Page:451-456
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Shotan Avraham,Widerhorn Josef,Hurst Agneta,Elkayam Uri

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. Plasma renin activity during ovine pregnancy;Fleischman;Am J Physiol.,1975

2. Control of vascular responsiveness during human pregnancy;Gant;Kidney Int.,1980

3. Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy;Hanssens;Obstet Gynecol,1991

4. Angiotensin-converting enzyme inhibitors, an embryopathic class of drugs with unique properties: information for clinical teratology counselors;Brent;Teratology,1991

5. Hypertension in pregnancy;Lindheimer;NEJM,1985

Cited by 281 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Cross-Sectional Study about Demographic and Medical Characteristics of Hypertensive Pregnant Women in Two Secondary Healthcare Facilities, in Ilorin, Nigeria;Libyan International Medical University Journal;2024-02-09

2. Heart failure in pregnancy;Critical Heart Condition During Pregnancy;2024

3. miRNA-767 and its binding site polymorphism in the mTOR gene act as potential biomarkers for female reproductive cancers;Future Oncology;2023-09

4. Peripartum Cardiomyopathy: Risks Diagnosis and Management;Journal of Multidisciplinary Healthcare;2023-05

5. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease;Kidney International;2022-11